The original version of this story appeared in Quanta Magazine. In 1939, upon arriving late to his statistics course at UC Berkeley, George Dantzig—a first-year graduate student—copied two problems ...

A new grant from the Valhalla Foundation will help Octave Bioscience advance the development of a biomarker blood test for detecting disease progression in people with multiple sclerosis (MS). The ...

Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. This satellite image provided by the National ...

This storm is no longer being tracked. Octave was a post-tropical cyclone in the North Pacific Ocean Thursday morning Pacific time, the National Hurricane Center said in its latest advisory. Octave is ...

Introduction: In unsupervised learning, data clustering is essential. However, many current algorithms have issues like early convergence, inadequate local search capabilities, and trouble processing ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Octave Bioscience, Inc., a commercial stage precision care company that is pioneering a new standard for managing multiple sclerosis (MS) and other ...

Two fast-growing artificial intelligence companies are betting that the future of sales lies not in hiring more salespeople, but in creating an entirely new type of professional that combines revenue ...

STOCKHOLM, Sweden — As Hexagon AB prepares for the potential spin-off of Hexagon’s Asset Lifecycle Intelligence and Safety, Infrastructure & Geospatial divisions and related businesses, the company ...

Octave Bioscience’s Multiple Sclerosis Disease Activity (MSDA) test, which uses data from blood biomarkers to assess multiple sclerosis (MS) disease activity, is now available across all 50 U.S.

OXFORD, England--(BUSINESS WIRE)--A new paper, released this week on bioRxiv, introduces hifiasm-ONT, a breakthrough genome assembly algorithm that enables partially phased, near telomere-to-telomere ...